清炎颗粒治疗尿路感染的临床疗效及安全性研究  

The Clinical Effects and Security of Qingyan Granula on Patients with Urinary Tract Infection

作　　者：汤璐敏[1] 陈素英[1] 李祎群[1] 李鹤[1] 沈惠风[1] 

机构地区：[1]上海交通大学医学院附属仁济医院中医科,上海200127

出　　处：《中国医药导刊》2012年第12期2112-2112,2114,共2页Chinese Journal of Medicinal Guide

基　　金：上海市科学技术发展基金资助项目(No034119923)

摘　　要：目的:观察清炎颗粒治疗尿路感染的临床疗效及安全性研究。方法:将109例尿路感染患者随机分成2组,治疗组78例,予清炎颗粒;对照组31例,予环丙沙星胶囊。结果:治疗组总有效率为88.5%,治疗组与对照组总有效率无显著性差异(P>0.05),治疗前后肝肾功能无明显变化(P>0.05)。结论:清炎颗粒治疗尿路感染疗效与环丙沙星相当,是有效的,安全的。Objective：To evaluate therapeutic effect and Security of Qingyan Granula.Methods：Total 109 patients were randomly divided into treatment group and control group.Qingyan granula was used in treatment group while ciprofloxacin capsule was used in control group.Results：（1）The total effective rate of treatment group was 88.5% The total effective rate of treatment group was no significant difference between that of control group（P0.05）.The liver,renal function had no significant change before and after treatment .Conclusion：The application of Qingyan granula in urinary tract infection is effective,safe.

关 键 词：尿路感染 清炎颗粒 临床疗效 安全性 

分 类 号：R691.3[医药卫生—泌尿科学]